Navigation Links
First clinical trials successfully completed on potent new hepatitis C drug
Date:9/3/2010

The first clinical trials on a new investigational drug being developed to treat infections caused by Hepatitis C virus have been successfully completed.

Completion of the initial phase (phase 1a) of trials of INX-189, discovered and first prepared by researchers at Cardiff University's Welsh School of Pharmacy in 2008, means the chances of it becoming an approved medicine have significantly improved.

Approximately 170 million people worldwide are affected with Hepatitis C, which can lead to liver cancer, cirrhosis and death. It is the leading cause of liver transplantation in western countries. The current treatment involves two drugs ribavirin and interferon, which has to be given as an injection. Side effects are often severe and lead to patients failing to complete the treatment.

Professor Chris McGuigan of the Welsh School of Pharmacy, academic lead on the project, said: "This is still a very early stage of the trials process but none the less a significant development. Successfully completing phase 1a demonstrates that the drug is safe, with no drug-related side effects at all in a single dose of 100mg.

"The efficiency of drug release in this study has also confirmed that one single dose a day is most likely enough in treating the virus.

"We believe that INX-189 offers the possibility of more potency against Hepatitis, more rapid action in the liver, and fewer side effects than existing treatments."

In 2008, laboratory tests showed INX-189 killed 90 per cent of the virus at very low (nanomolar) concentration, making it the most potent compound of its kind developed to date.

US pharmaceutical company Inhibitex, which owns the licence to INX-189 and has been working with the Cardiff team, has announced it is looking forward to a second trial (phase 1b), which would evaluate the compound's effectiveness in Hepatitis C patients.

Cardiff University and Inhibitex filed a patent on INX-189 earlier
'/>"/>

Contact: Lowri Jones
joneslc3@cardiff.ac.uk
Cardiff University
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Almost 1 in 3 First-Time Deliveries Now Via C-Section
2. For the first time, researchers identify and isolate adult mammary stem cells in mice
3. Gold Standard/Elsevier first to launch state, federal controlled substance drug schedules
4. Southampton to conduct UKs first cochlear implant operation to give sound in both ears
5. Neuralstem files FDA application for first chronic spinal cord injury stem cell trial
6. K-State professors book is first to explore Two-Spirit literature in Northwest native groups
7. Deaf, hard-of-hearing students perform first test of sign language by cell phone
8. CRF announces late breaking trials and first report investigations to be presented at TCT 2010
9. Doctors hard to find for patients in Massachusetts first for-profit health plan
10. Scientists develop the first model for investigating the origins of testicular cancer in humans
11. UCLA scientists for the first time identify a cell-of-origin for human prostate cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... A group of 127 scientists sent an “open ... to a recent statement by the center that was highly ... the efficacy of all brain exercises. , Signatories to the ... the center’s statement critical of brain exercise companies that overstate ... its case, in a document it had entitled “A Consensus ...
(Date:12/17/2014)... No matter how far modern medicine advances, it ... louse parasite—a common childhood malady and a source of ... and twelve million individuals will suffer an infestation. ... comes to the rescue, providing an all-natural treatment that ... record of customer service, and effectiveness in getting rid ...
(Date:12/17/2014)... Project Veritas is releasing a video interview ... economist and Obamacare architect Jonathan Gruber to public attention. ... interview, which is being distributed on YouTube. , During ... in the Affordable Care Act in order to hide ... dollar per year tax grab. , “President Obama promised ...
(Date:12/17/2014)... Alan Mozes HealthDay Reporter ... world of infectious diseases, one worrisome phenomenon is when an ... The process -- known as zoonosis -- is not uncommon ... signs that an animal-borne disease might make inroads into the ... a development -- and the culprits in this case were ...
(Date:12/17/2014)... students get more fruits and vegetables at school than they ... opposite is true for students from wealthier families. These ... give a healthy boost to poor students, diets, according to ... level, students all ate a similar amount of fruits and ... published recently in the journal Preventive Medicine . ...
Breaking Medicine News(10 mins):Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 2Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 3Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 4Health News:Lice Troopers Announces New Lice Treatment Clinic in Coral Gables to Service Key Biscayne, Coconut Grove, Kendall, Brickell & South Miami 2Health News:Project Veritas: James O’Keefe Interviews the Man Who Discovered Jonathan Gruber Videos 2Health News:Guinea Pigs Can Be Source of Serious Strep Infection 2Health News:Guinea Pigs Can Be Source of Serious Strep Infection 3Health News:Poor Students Eat Healthier Foods at School, Study Finds 2
... of Meijer ... customers, ... Legacy of Leadership award in recognition of its free,antibiotic and free ... Service Awards luncheon of Michigan,Primary Care Association (MPCA), the nonprofit membership ...
... CHAPEL HILL A new study seeking to improve scientists, ... is higher in African-American women, is getting underway in 44 ... late Jeanne Hopkins Lucas, a North Carolina state senator who ... the Lineberger Comprehensive Cancer Center at the University of North ...
... time, increase physician productivity,and safety, WASHINGTON, ... wait time, and improve quality of care, ... voluntary consensus standards for,hospital-based emergency department care. ... coordination in emergency departments where high demand,and ...
... Corporation Award Based on Consistent, Long-term Revenue Growth, ... HSKA ) ("Heska") today announced it has ... by Deloitte LLP. The Technology Fast,50 lists the ... companies in Colorado based on percentage revenue growth ...
... type 1 a rare disease in which tumors grow ... by crosstalk between cells in the nerves and cells in ... National Institutes of Health (NIH) and the Department of Defense ... treating certain kinds of blood cancer curbs tumor growth in ...
... - Response Biomedical,Corporation (TSX: RBM, OTCBB: RPBIF) announces ... Rapid Detection Flu A+B Test at the 48th ... launching,the RAMP(R) Influenza A/B Assay in the United ... 3M(TM) Rapid Detection Flu A+B Test. This rapid ...
Cached Medicine News:Health News:Meijer Honored by Michigan Primary Care Association for Leadership in Promoting Health of Michigan Residents 2Health News:Meijer Honored by Michigan Primary Care Association for Leadership in Promoting Health of Michigan Residents 3Health News:UNC Lineberger launches 44-county study of breast cancer in black women 2Health News:UNC Lineberger launches 44-county study of breast cancer in black women 3Health News:NQF Endorses Measures to Address Care Coordination and Efficiency in Hospital Emergency Departments 2Health News:NQF Endorses Measures to Address Care Coordination and Efficiency in Hospital Emergency Departments 3Health News:Deloitte Names Heska Corporation to Colorado Technology Fast 50 2Health News:Deloitte Names Heska Corporation to Colorado Technology Fast 50 3Health News:Researchers identify mechanism, possible drug treatment for tumors in neurofibromatosis 2Health News:Researchers identify mechanism, possible drug treatment for tumors in neurofibromatosis 3Health News:Response Biomedical Announces Launch of RAMP(R) Technology in 3M(TM) Rapid Detection Flu A+B Test at ICAAC/IDSA Conference 2Health News:Response Biomedical Announces Launch of RAMP(R) Technology in 3M(TM) Rapid Detection Flu A+B Test at ICAAC/IDSA Conference 3Health News:Response Biomedical Announces Launch of RAMP(R) Technology in 3M(TM) Rapid Detection Flu A+B Test at ICAAC/IDSA Conference 4
(Date:12/15/2014)... and BRIDGEWATER, N.J. , ... REGN) and Sanofi US (EURONEXT: SAN and NYSE: SNY) ... organizations to launch Cholesterol Counts , an awareness ... cholesterol, their numbers, and the risks associated with high ... www. CholesterolCounts .com to take a brief ...
(Date:12/15/2014)... , Dec. 15, 2014   DaVita ... one of the nation,s largest and most innovative ... its business units, DaVita Clinical Research  (DCR) and  ... to further expand its extensive clinical research and ... kidney disease (CKD) and end-stage renal disease (ESRD), ...
(Date:12/13/2014)... , December 12, 2014 ... announced the addition of the  "Global Catheters ... Share, Global Trends, Company Profiles, Analysis, Segmentation ... to their offering.       (Logo: ... made up of medical grade material such ...
Breaking Medicine Technology:Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 2Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 3Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 4Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 5Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 6DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical Trials and Data Analytics Capabilities 2DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical Trials and Data Analytics Capabilities 3DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical Trials and Data Analytics Capabilities 4Global Catheters Market (Product Types and Geography) - Forecast to 2020 2Global Catheters Market (Product Types and Geography) - Forecast to 2020 3
... 2, 2011 Aoxing Pharmaceutical (NYSE Amex: ... company focusing on research, development, manufacturing and distribution ... operating subsidiary in China, Hebei Aoxing Pharmaceutical Group ... State Intellectual Property Office of The People,s Republic ...
... TARRYTOWN, N.Y., May 2, 2011 Regeneron Pharmaceuticals, Inc. (Nasdaq: ... of America Merrill Lynch 2011 Health Care Conference on Tuesday, ... Eastern Time).  The session may be accessed through the Company,s ...  An archived version of the presentation will be available after ...
Cached Medicine Technology:Aoxing Pharmaceutical Company Announces Issuance of Chinese Patent for Naloxone Sublingual Film 2Aoxing Pharmaceutical Company Announces Issuance of Chinese Patent for Naloxone Sublingual Film 3
... of a heartbeat. The bodys warmth beneath ... These vital signs are yours to guard, ... of Temperature Monitoring products helps you do ... to provide the most comfortable and precise ...
... The bodys warmth beneath drapes. The life-giving ... are yours to guard, measure, stabilize and ... products helps you do your job, giving ... most comfortable and precise management of your ...
... stabilization of the capsular bag in complicated ... Tension Ring has application in several different ... available for patients with pseudoexfoliation syndrome. Many ... tension ring, especially those in whom you ...
... The Smartlipo laser provokes the breaking ... adipose cells, transforming them into an ... eliminated in a natural manner. ... harmonious body shape in a short ...
Medicine Products: